Myriad Genetics MYGN
NASDAQ MYGN
$3.17 +0.06 (+1.76%)
As of: Aug 27, 2026 · 3:59 PM EDT

Myriad Genetics (MYGN) Non Operating Interest Expenses (2009 - 2026)

Myriad Genetics (MYGN) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 401.00 Mn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 107.00 Mn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 890,000.00
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 25.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 197.00 Mn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 10.18 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn 24.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 17.25 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 61.10 Mn
10 Myriad Genetics 300.99 Mn 185.79 Mn 127.00 Mn 4.10 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 4.10 Mn
Mar 31, 2026 4.10 Mn
Dec 31, 2025 4.40 Mn
Sep 30, 2025 3.80 Mn
Jun 30, 2025 1.50 Mn
Mar 31, 2025 800,000.00
Dec 31, 2024 700,000.00
Sep 30, 2024 800,000.00
Jun 30, 2024 800,000.00
Mar 31, 2024 500,000.00
Dec 31, 2023 900,000.00
Sep 30, 2023 1.00 Mn
Jun 30, 2023 500,000.00
Mar 31, 2023 500,000.00
Dec 31, 2022 900,000.00
Sep 30, 2022 800,000.00
Jun 30, 2022 600,000.00
Mar 31, 2022 900,000.00
Dec 31, 2021 500,000.00
Sep 30, 2021 1.10 Mn